Jump Financial’s Otonomy, Inc. OTIC Stock Holding History

Jump Financial’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-23,111	Closed	-$59K	–	1493
2021 Q1	$59K	Buy	+23,111	New	+$94.7K	0.01%	871

Other funds holding OTIC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Jump Financial's OTIC Position: Q2 2021 in Review

Jump Financial sold out of Otonomy, Inc. (OTIC) in Q2 2021, closing a stake of 23,111 shares — an estimated $59K sold.

Jump Financial first reported a position in OTIC in Q1 2021 and held it in 1 quarter. The position peaked at $59K in Q1 2021. 59 funds tracked by Wall St. Rank hold OTIC as of Q2 2021.

Jump Financial reported no remaining Otonomy, Inc. position as of Q2 2021 after selling out during the quarter.
Jump Financial sold 23,111 Otonomy, Inc. shares in Q2 2021, an estimated $59K.
Jump Financial first reported a position in Otonomy, Inc. in Q1 2021 and held it in 1 quarter.
Jump Financial's Otonomy, Inc. position peaked at $59K in Q1 2021.
59 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q2 2021.

Based on Jump Financial's 13F filing for Q2 2021, filed 13 Aug 2021.